AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intro
This chapter explores a congressional hearing on the pricing of weight loss drugs by Novo Nordisk, highlighted by significant debates on corporate greed in healthcare. It examines the moral dilemmas of balancing drug development costs against the need for affordable access to life-changing treatments, featuring notable advocates like Bernie Sanders.